GeneSight, a Mason-based company specializing in mental health medication, expanded its wellness services in the community.

Myriad Genetics continues to pursue a resolution with UNH that allows for its commercial enrollees to continue to have access to the GeneSight test ... circulating tumor DNA (ctDNA), which ...

However, a significant challenge emerged when UnitedHealthcare decided to discontinue coverage for multi-gene panel pharmacogenetic testing, including Myriad’s GeneSight test, from January 2025 ...

GeneSight revenue per test improved both year-over-year and quarter ... a personalized method for detecting circulating tumor DNA. In addition, our agreement with Personalis to cross-license ...

This repo is dedicated for storing various Kubernetes-related performance test related tools. If you want to add your own load-test, benchmark, framework or other tool please contact with one of the ...

But the good news is, getting tested is usually quick, easy, and painless. And STDs can be cured or treated. Planned Parenthood health centers offer STD testing and treatment, and our caring and ...

Nov. 7, 2024 — Researchers have used ancient DNA to challenge long-held interpretations of the people of Pompeii. Contrary to physical appearances, the DNA evidence revealed unexpected ...

Sign up for CNN’s Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. Ancient DNA has ...

Thank you, Briana. Good afternoon, and welcome to Tempus’ third quarter 2024 conference call. This afternoon, Tempus released results for the quarter ending September 30, 2024. Joining me today from ...

This web site is for people studying for an English language exam.

Despite the setback from UnitedHealth’s decision not to cover the GeneSight assay ... and marketing of transformative molecular diagnostic test. It operates through the Diagnostics and Other ...